Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Heisman
    Senior Member
    • Dec 2010
    • 534

    #1

    Counting CpG's per read, please check my logic.

    Simple question but I want to make sure I get this right. Basically I'm looking at pulldowns of regions enriched with methylated CpG's.

    Let's say I have a read that has the sequence: ACGTCGTACGCGTGCAAGCGC

    The "CG" sequence appears 5 times.
    The "GC" sequence appears 4 times.
    However, there are only 7 distinct occurrences of "CG" or "GC" as one "CG" overlaps "GCGC" and one "GC" overlaps "CGCG".

    A read may overlap the forward or reverse strand but either way CG will appear as the reverse complement of CG is CG.

    Thus, I should only consider sequences of C followed by G, and not G followed by C, correct? Hence, in the above read, it will cover 5 CpG sites?

    Is this correct logic?
  • C.R.
    Member
    • Jun 2010
    • 25

    #2
    I would say your are correct. If you focus on CpGs then you should stay with the CG which is the same in forward and reverse orientation.

    Comment

    • mastal
      Senior Member
      • Mar 2009
      • 666

      #3
      Originally posted by Heisman View Post


      Is this correct logic?
      Yes, it is correct.

      Comment

      • dpryan
        Devon Ryan
        • Jul 2011
        • 3478

        #4
        I'll add to the choir in saying, yes, that's correct. A G followed by a C is a GpC, not a CpG. A motif such as GCAA (i.e., a GpC or a CHH motif) generally has a very low rate of methylation, so you wouldn't expect it to contribute appreciably to the pull-down.

        I imagine the fact that we focus on CpG sites and then talk about GC content can create a bit of confusion :P

        Comment

        • Heisman
          Senior Member
          • Dec 2010
          • 534

          #5
          Excellent, thanks everyone.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            10-14-2026, 09:55 AM
          • SEQadmin2
            New Genomics Technologies Take Aim at Long-Standing Limits
            by SEQadmin2


            Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

            We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
            ...
            09-28-2026, 10:25 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 10-15-2026, 10:52 AM
          0 responses
          17 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-14-2026, 05:39 AM
          0 responses
          26 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-13-2026, 09:56 AM
          0 responses
          22 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-09-2026, 11:14 AM
          0 responses
          28 views
          0 reactions
          Last Post SEQadmin2  
          Working...